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Reaction of Fumonisin with Glucose Prevents Promotion of
Hepatocarcinogenesis in Female F344/N Rats while Maintaining
Normal Hepatic Sphinganine/Sphingosine Ratios
Hongjun Liu,† Yun Lu,† Joseph S. Haynes,‡ Joan E. Cunnick,§ Patricia Murphy,† and
Suzanne Hendrich*,†
Department of Food Science and Human Nutrition, Department of Veterinary Pathology,
and Department of Microbiology, Iowa State University, Ames, Iowa 50011
The reaction of the primary amine of fumonisin B1 (FB1) with glucose was hypothesized to detoxify
this mycotoxin. Eighty 10-day-old female F344/N rats were injected intraperitoneally with
diethylnitrosamine (DEN; 15 mg/kg of body weight). At 4 weeks of age, the weaned rats were
randomly assigned to one of four treatment groups with 20 rats each. At 9 weeks of age, four rats
from each treatment group were killed. At 12 weeks, another five rats from each group were killed.
At 20 weeks of age, the remaining rats were killed. In comparison with the rats fed basal diet or
FB1-glucose (containing 25 ppm of FB1), rats fed 8 ppm (residual amount of free FB1 in the FB1-
glucose mixture) or 25 ppm of FB1 had greater alanine aminotransferase activity at 9 and 20 weeks
of age (P < 0.001), greater endogenous hepatic prostaglandin E2 production at 20 weeks of age (P
< 0.05), and significantly lower plasma cholesterol at 20 weeks of age (P < 0.01). Placental
glutathione S-transferase (PGST)-positive and ç-glutamyltransferase (GGT)-positive altered hepatic
foci (AHF) occurred only in rats fed 25 ppm of FB1 at 20 weeks of age. Hepatic natural killer (NK)
cell activities were similar among the four groups, but the percentage of total liver-associated
mononuclear cells exhibiting the NKR-P1bright marker was significantly greater in rats fed FB1-
glucose, FB1 (8 ppm) and FB1 (25 ppm) than in control rats at 9 weeks of age, and FB1-glucose-
treated rats had significantly lower NKR-P1bright cells as a percentage of total liver-associated
mononuclear cells than rats fed 25 ppm of FB1 at 20 weeks of age (P < 0.05). PGST- or GGT-
positive AHF were not detected in any treatment group at 9 or 12 weeks of age. At 20 weeks of age,
half of the rats fed 25 ppm of FB1 had PGST- and GGT-positive AHF. The sphinganine (Sa)
concentration and the Sa/sphingosine (So) ratio were significantly greater in the rats fed 25 ppm of
FB1 diet as compared with the control groups at, respectively, 12 or 20 weeks of age. Therefore,
modifying FB1 with glucose seems to prevent FB1-induced hepatotoxicity and promotion of
hepatocarcinogenesis. The Sa/So ratio was not the most sensitive biomarker of FB1 toxicity.
Keywords: Glucose; hepatic; rats; fumonisin; carcinogenesis
INTRODUCTION
The carcinogenic and toxic effects of fumonisin B1
(FB1), a mycotoxin produced by the commonly occurring
corn fungi, Fusarium moniliforme and Fusarium pro-
liferatum, have been studied intensively. Fumonisin B1
(69.3 ímol/kg, 50 ppm) was hepatocarcinogenic in rats
fed the toxicant for 2 years (1). The incidence of F.
moniliforme in corn for human consumption has been
correlated with the incidence of esophageal cancer in
Transkei, southern Africa (2), and in China (3). The
concentration of FB1 in corn reached 11.1 ímol/kg in
areas of southern Africa where the human esophageal
cancer rate was high (4). Corn products for human and
animal consumption were determined to contain 0.3-
4.2 ímol of FB1/kg in the United States (5-7).
Several biomarkers have been used to study FB1
hepatocarcinogenicity. FB1-promoted rat hepatocarcino-
genesis was readily quantified by measuring placental
glutathione S-transferase (PGST)-positive altered he-
patic foci (AHF) (8) and ç-glutamyltransferase (GGT)-
positive AHF (9). Plasma alanine aminotransferase
(ALT) activity was increased during fumonisin hepato-
toxicity (10) and hepatocarcinogenesis in rats (11).
Increased plasma total cholesterol was observed in
FB1-treated vervet monkeys (12) and in rats (11) in
short-term studies. Greater hepatic prostaglandin F2R
production was also observed in FB1 tumor promotion
in rat liver (13). In vivo administration of 50 ppm of
FB1 significantly suppressed hepatic natural killer (NK)
cell activity while stimulating hepatic preneoplasia (13).
NK cell activity suppression by FB1 during tumor
promotion may be mechanistically significant, but this
remains to be determined. Thus, numerous possible
biomarkers of FB1 toxicity and tumor promotion may
be used to probe the mechanism of action of this
mycotoxin.
Fumonisins selectively inhibit ceramide synthase, a
key enzyme in the sphingolipid biosynthetic pathway
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(14). The subsequent accumulation of the sphingoid
bases, sphinganine (Sa) and sphingosine (So), could
have an important role in the toxicological effects of
fumonisin in the kidney and liver of rats (15, 16).
Because the sphingoid bases are important regulators
of cellular growth and differentiation (17), disruption
of sphingolipid biosynthesis has been implicated in the
hepatocarcinogenicity of fumonisin (18).
Many strategies have been examined for the reduction
of human and animal exposure to these fungal toxins.
Biological, chemical, and physical processes have been
explored to salvage fumonisin-contaminated corn. The
thermostability of FB1 proved to be great. When dry
corn was heated at 50, 75, 100, and 125 °C for 40 min,
only a small amount of FB1 was lost (19). Treatment of
fumonisin-contaminated corn with 2% ammonia for 4
days, a process that detoxified aflatoxin B1, led to a
slight reduction in the concentration of FB1 without
decreasing its toxicity in rats (15). Nixtamalization, the
traditional process to produce masa or tortilla flour,
reduced the amount of FB1 by hydrolyzing FB1 to
hydrolyzed FB1 (HFB1 ), but HFB1 was similar in
toxicity to FB1 when the nutritional status of rats was
adequate (11). In vitro toxicity studies of several FB1
analogues showed that the analogues containing FB1
amine groups and the tricarballylic side chains were
more toxic than analogues containing only the tri-
carballylic side chains (20), and naturally occurring
N-acetyl-FB1 was not toxic (21). Therefore, the primary
amine of FB1 is likely to be critical for its toxicity.
Murphy et al. (22) reported a method to detoxify FB1
by derivatizing the amine group with a reducing sugar,
fructose, in a nonenzymatic browning reaction. Di-
ethylnitrosamine-initiated (15 mg/kg of body weight)
male F344/N rats were fed for 4 weeks either 69.3 ímol
of FB1/kg or 69.3 ímol of FB1/kg reacted with fructose
(FB1-fructose). Rats fed FB1 had significantly greater
biomarkers of hepatocarcinogenicity, whereas rats fed
FB1-fructose showed no signs of hepatocarcinogenicity
or hepatotoxicity (13). A more practical and efficient
method to block FB1’s amine group by reacting the
amine group with glucose had been developed in Dr.
Murphy’s laboratory (23). The FB1-glucose reaction was
more complete than the reaction with fructose, and the
reaction products were more easily isolated than FB1-
fructose products. It was hypothesized that modifying
FB1 with glucose would prevent promotion of hepato-
carcinogenicity by FB1. Our experiment was designed
to test the effectiveness of this detoxification method
by examining the effects of FB1-glucose on several
markers of FB1 promotion of hepatocarcinogenesis.
MATERIALS AND METHODS
Preparation of Fumonisin B1)Glucose Adduct. FB1-
glucose was prepared by heating 1.39 mM FB1 (total ) 8.1
mmol) with 0.1 M D-glucose in 50 mM potassium phosphate
buffer, pH 7.0, at 80 °C. After 48 h, the pH of the reaction
mixture was adjusted to pH 2.7 to stop the reaction. Reversed-
phase C18 SPE cartridges (Supelco, Bellefonte, PA) were
preconditioned with 50 mL of 100% methanol at an apparent
pH of 2.7 followed by 100 mL of deionized water at an apparent
pH of 2.7. An aliquot of 50 mL of the 1.39 mM FB1/0.1 M
D-glucose reaction mixture was loaded onto the cartridge. The
cartridge was washed with 100 mL of deionized water and 100
mL of 30% methanol at an apparent pH of 2.7. The D-glucose
was washed out at this step. The FB1-glucose was eluted with
50 mL of 40% methanol and 100 mL of 100% methanol at an
apparent pH of 2.7. The eluent was evaporated to dryness with
a Brinkmann rotavapor R110 (Westbury, NY) at 35 °C. The
residue was redissolved in distilled deionized water and
brought to 10.0 mL in a volumetric flask. The unreacted free
FB1 was detected by HPLC after derivatization with o-
phthalaldehyde (5). The solution was freeze-dried and the total
mass determined on an analytical balance. The amount of FB1-
glucose was determined by subtracting the free FB1 mass from
the total mass.
Diets. Four experimental diets were fed to rats. The control
group was fed basal diet AIN-93G (24). The FB1 group was
fed a diet containing highly purified FB1 that was prepared
by incorporating 25 ppm of FB1 into basal diets. The FB1-
glucose group was fed a diet in which purified FB1 reacted
with glucose was incorporated into the basal diet at a level
equivalent to 25 ppm of FB1 diet. Analysis of the FB1-glucose
products showed that 8 ppm of unreacted FB1 remained in
the FB1-glucose-containing diet. Thus, another control group
was fed 8 ppm of FB1.
Animals. The experimental procedures were approved by
the Iowa State University Animal Care Committee. Eighty 10-
day-old female F344/N rats obtained from Harlan Sprague-
Dawley (Madison, WI) were injected intraperitoneally with
diethylnitrosamine (DEN; 15 mg/kg of body weight) in 0.1 mL
of corn oil. At 4 weeks of age, the weaned rats were randomly
assigned to one of the four treatment groups with 20 rats each.
At 9 weeks of age, four rats from each treatment group were
killed. At 12 weeks, another five rats from each group were
killed. At 20 weeks of age, the remaining rats were killed. The
carcasses of the rats were stored at -20 °C in a freezer. Before
scanning by dual-energy X-ray absorptiometry (QDR 2000,
Hologic Inc., Waltham, MA), the carcasses were thawed at 0
°C for 2 h. The amounts of lean and fat tissues in the body
were expressed as a percentage of the body weight (25). Rats
were given free access to the experimental diets and were
exposed to a 12-h light/dark cycle maintained at 22-25 °C and
50% humidity. Body weight and feed intake were recorded
weekly.
Plasma and Liver Sample Preparations. Before the liver
was perfused, 1 mL of 0.85% sodium chloride solution (con-
taining 100 units of heparin) was injected into the abdominal
vein, and 3 mL blood was removed. Part of the plasma
obtained from the heparinized blood was analyzed within 24
h for ALT activity. The remaining plasma was stored at -80
°C for later plasma total cholesterol analysis.
Rat livers were perfused with 40 mL of Hank’s balanced
salt solution (HBSS, supplemented with 25 mM Hepes and
0.1% EDTA). Approximately 12 mL of perfusate was concen-
trated to 3 mL, laid on 3 mL of Accupaque density gradient
medium (Accurate Chemical Co., Westbury, NY), and then
centrifuged at 1500 rpm for 10 min. The mononuclear cells at
the interface were collected and washed two times, once with
HBSS (with 25 mM Hepes) and once with complete medium
[RPMI-1640, supplemented with 50 íg/mL gentamicin, 25 mM
Hepes, 2 mM l-glutamine, and 10% fetal bovine serum (FBS)].
Cells were enumerated on a Celltrack II (Nova Biomedical,
Waltham, MA), in preparation for the NK cell activity and cell
surface immunofluorescence analysis.
Each of the left, median, and right lateral lobes of the livers
was sliced into 1 cm slices. Three slices, one from each lobe,
were immediately frozen as a block on dry ice and stored at
-80 °C. From each of the frozen liver blocks were cut five 10-
ím serial sections with a Histostat microtome (model 855,
Leica Inc., Deerfield, IL) for later staining of GGT and PGST.
For each rat, a portion of 0.5 g of minced liver was
immediately homogenized in an ice bath with 10 passes of a
Potter-Elvehjem homogenizer in 5 mL, pH 7.4, 50 mM potas-
sium phosphate buffer containing 4.2 mM acetyl salicylic acid
(Sigma Chemical Co., St. Louis, MO). The liver homogenates
were frozen at -80 °C for later analysis of endogenous hepatic
PGE2 and PGF2R.
Plasma Total Cholesterol Concentration and ALT
Activity. Plasma total cholesterol concentration was deter-
mined by using a Sigma diagnostic kit, procedure 352-3 (Sigma
Chemical Co.). Plasma ALT activity was measured by using a
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Sigma diagnostic kit for glutamate/pyruvate transaminase
optimized for the ALT assay (Sigma Chemical Co.).
Determination of Sphingosine (So) and Sphinganine
(Sa). Thawed liver tissues were homogenized in 4 volumes 0.05
M potassium phosphate buffer. Homogenate (0.1 mL) was
transferred to a cold (13  100 mm) glass tube with a Teflon-
lined screw cap. The extraction method was performed as
described by Riley et al. (26). Sphingosine and sphinganine
were quantified by HPLC as described by Riley et al. (26) but
using C17-phytosphingosine (Sigma Chemical Co.) as the
internal standard. The C17-phytosphingosine, Sa, and So
standard (Sigma Chemical Co.) mixture at different concentra-
tions (1, 3, 5, 7, and 9 nmol) were prepared for standard curves.
Prostaglandin Assays. PGE2 and PGF2R were determined
in a radioimmunoassay as described by McCosh et al. (27).
Anti-PGE2 antiserum (0.2 mL/per assay tube) and anti-PGF2R
antiserum (0.2 mL/per assay tube) were obtained from Sigma
Chemical Co. H3-PGE2 (10-6 íCi/aliquot) and H-PGF2R (10-6íCi/
aliquot) were obtained from NEN Products (Boston, MA). PGE2
and PGF2R were quantified by using a computer program based
on a logit transformation of the standard curve (28).
NK Cell Assays. NK cell assays were performed as previ-
ously described (29). Cells were plated in triplicate at the
following effector to target ratios in 96 well plates: 25:1, 12.5:
1, 6.25:1, and 3:1. The target cells for the assay were YAC-1
cells (ATCC Co., Rockville, MD) (8  103/well), which had been
labeled with 200 íCi of 51Cr. The amount of 51Cr released by
dying cells was counted using a Gamma Trac 1191 (TM
Analytic, Inc., Elk Grove Village, IL). Lytic units were calcu-
lated using a computer program based on the equation of Pross
and Maroun (30).
Fluorescent Staining of Lymphoid Cells. Leukocyte
suspensions were diluted with an equal volume of PBS/0.1%
azide (cold) and incubated at 4 °C (5 min). Separate aliquots
were stained with 0.2 íg/2  105(mononuclear cell) of anti-rat
NKR-P1A-Biotin (mAb 3.2.3) or an equivalent amount of
isotype control (murine IgG1-biotin). A second step of 0.1 íg/2
 105(mononuclear cell) Strep-AvidinCychrome was used (all
from Pharmingen, San Diego,CA). All incubations were per-
formed at 4 °C in the dark for 30 min and washed with PBS/
0.1% azide. The contaminating red blood cells were lysed using
10% ammonium chloride buffer (pH 7.4). Cells were fixed with
PBS/1% paraformaldehyde prior to analysis using an EPICS-
XL-MCI flow cytometer (Coulter, Miami, FL). According to the
density of fluorescence, three cell populations were distin-
guished, NKR-P1bright, NKR-P1dim, and negative, and gates
were set to help measure the percentages of different popula-
tions (31) (Figure 1).
Immunohistochemical Staining. One of the frozen serial
sections was stained for the presence of PGST-positive AHF.
PGST was detected by the peroxidase-anti-peroxidase (PAP)
method using a Vectastain ABC avidin-biotin universal rabbit
PAP kit (Vector Laboratories, Burlingame, CA). Anti-PGST
antiserum was prepared as described previously (32). The
second frozen serial section was stained for GGT activity as
described by Rutenburg et al. (33). The substrate for GGT was
glutamyl-4-naphthylamide (GMNA) (United States Biochemi-
cal Corp., Cleveland, OH). AHF were quantified via computer-
ized stereology. A Sony three-chip color video camera DXC-
3000A took the images of the liver section stained for GGT
and PGST, which were digitally transferred from the camera
to an Apple Power Mac G3 computer (Apple Computer, Inc.,
Cupertino, CA) and analyzed with IP Lab image analysis
software (version 3.2.3, Scanalytics, Fairfax, VA). Lung,
kidney, brain, tibia, and additional liver samples were proc-
essed by routine histopathological methods for hematoxylin-
eosin staining (34).
Statistical Analysis. Multivariant regression analysis was
used to compare the four growth curves. One-way ANOVA was
performed to analyze plasma total cholesterol, ALT activity,
and the percentage of leukocytes that carry NKR-P1bright and
NKR-P1dim population markers as well as the amounts and
ratio of Sa/So. The hepatic NK activity was compared using
one-way ANOVA combined with covariance for the percentage
of NKR-P1bright population. Two-way ANOVA was performed
to analyze endogenous PGE2 and PGF2R at different ages.
Student’s t test was performed to compare all possible group
differences after ANOVA. A P value of <0.05 was considered
to be statistically significant.
RESULTS
Effect on Body Weight Gains, Relative Liver
Weight, and Body Mass Composition. The body
weights and food intakes did not differ among treat-
ments. Relative liver weights were not different among
the four treatment groups at any time point, and body
compositions (percent fat) were similar among all groups
at 20 weeks of age. Body weights and food intakes did
not differ among treatments (Table 1). The growth
curves of four treatment groups were similar over a
period of 20 weeks (data not shown).
Plasma Total Cholesterol Levels and ALT Ac-
tivities. At 9 weeks of age, the total plasma cholesterol
concentrations were not different among the four treat-
ment groups. At 12 weeks of age, in comparison with
the rats fed basal diet and the rats fed FB1-glucose, the
rats fed 25 ppm FB1 diet had significantly greater
plasma total cholesterol concentration (P < 0.05). At 20
weeks of age, in comparison with the rats fed basal or
FB1-glucose diets, the rats fed 8 or 25 ppm FB1 diets
had significantly decreased plasma total cholesterol (P
< 0.05) (Figure 1). The ALT activity of the rats fed 8 or
Figure 1. Comparison of the total plasma cholesterol con-
centration at three time points. At 9 weeks of age, no difference
was found among four treatment groups. At 12 weeks, the rats
fed 25 ppm of FB1 exhibited significantly greater cholesterol
concentration as compared with the FB1-glucose group. At 20
weeks of age, both the rats fed with 8 ppm of FB1 and the rats
fed with 25 ppm of FB1 exhibited significantly lower cholesterol
concentration as compared with control group. The error bar
represents the standard error of the mean (SEM). “a” indicates
significant difference as compared with the FB1 (25 ppm) group
at 12 weeks of age (N ) 5/group). “b” indicates significant
difference as compared with the control group at 20 weeks of
age (N ) 10/group).
Table 1. Comparison of the Final Body Weights, Body
Mass Compositions, Relative Liver Weights, and Food
Intakes among Four Treatment F344/N Female Ratsa
body
wt (g)
liver wt/
body wt (%)
body
composition
(% fat)
food
intake
(g/day)
control 204 ( 12 4.1 ( 0.5 32.8 ( 3.0 13.5 ( 3.0
FB1-glucose 205 ( 12 3.9 ( 0.6 34.2 ( 5.0 14.5 ( 2.0
FB1 (8 ppm) 198 ( 15 3.9 ( 0.4 33.4 ( 3.0 12.8 ( 2.0
FB1 (25 ppm) 197 ( 16 3.7 ( 0.5 31.5 ( 2.0 11.5 ( 2.0
a No difference was found in these four indicators among these
groups under each treatment over 20 weeks (N ) 10/ group). The
data entries in the table are expressed as mean ( standard error
of mean (SEM).
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25 ppm diet was significantly greater than that of the
rats fed basal or FB1-glucose diet at 9 weeks age. At 12
weeks of age, only the rats fed 25 ppm of FB1 ex-
hibited significantly greater ALT activity than did other
groups. At 20 weeks of age, the rats fed 8 or 25 ppm of
FB1 exhibited greater ALT activity compared with rats
fed basal or FB1-glucose diet at 20 weeks of age (Figure
2).
Hepatic NKR-P1bright and NKR-P1dim Popula-
tions. Flow cytometric analysis using mAb 3.2.3 [NK
cell receptor protein 1 (NKR-P1)] revealed two distinct
subsets of hepatic mononuclear cells expressing variable
levels of NKR-P1. The NKR-P1bright population, which
expresses a high level of NKR-P1, has been identified
as the population causing NK-associated lytic activity
(35). The NKR-P1dim population, which expresses a low
level (2-10-fold lower) of NKR-P1, has been linked to a
subset of T lymphocytes that have an NK-like cytolytic
function under activation by interleukin 2 (36). The
results showed that all three treatment groups had
greater percentages of NKR-P1bright population at 9
weeks of age than did the control group. FB1-glucose
lowered the percentage of NKR-P1bright mononuclear
cells as compared with the group fed the 25 ppm diet
at 20 weeks of age (Figure 3A). The NKR-P1dim popula-
tions were not different among each group at three time
points, but with increasing age, each group had a
greater percentage of NKR-P1dim mononuclear cells as
compared with the same group at 9 weeks of age (Figure
3B).
Hepatic NK Cell Activity. Before covariation with
the percentage of NKR-P1bright population, all groups of
rats exhibited similar NK lytic activities at 9 and 12
weeks of age. The rats fed FB1-glucose exhibited sig-
nificantly lower NK lytic activity as compared with the
rats fed the 25 ppm FB1 diet at 20 weeks of age (Figure
4A). After covariation with the percentage of NKR-
P1bright mononuclear cells, all treatment groups exhib-
ited similar NK lytic activities at each age (Figure 4B).
Hepatic Concentration of PGE2 and PGE2r. The
hepatic PGE 2 concentrations were similar among all
groups at both 9 and 12 weeks of age, but hepatic
PGE2 concentration in rats fed both 8 and 25 ppm diets
was significantly increased by 50% as compared with
the control group at 20 weeks of age. With the age
increase, PGE2 concentrations in rats at 12 or 20 weeks
of age were significantly greater than that of rats fed
the same diets at 9 weeks of age (Figure 5). The PGF2R
concentrations were not different among treatments at
any time. Hepatic PGE2R was greater in all treatments
at 12 and 20 weeks of age than at 9 weeks of age (Figure
6).
AHF Indicated by PGST or GGT Staining. There
were no detectable PGST- or GGT-positive AHF in any
treatment group at 9 or 12 weeks of age. At 20 weeks
of age, half of the rats fed 25 ppm of FB1 had PGST-
and GGT-positive AHF. The average PGST-positive
AHF area percentage was 0.4 ( 0.7, and the average
GGT-positive AHF area was 0.6 ( 0.8. There were no
detectable PGST- or GGT-positive AHF foci in the
groups fed 25 ppm of FB1 reacted with glucose, 8 ppm
of FB1, or basal diet at 20 weeks of age (Table 2). Histo-
pathology studies showed that all of the groups exhib-
ited similar mild fatty changes in periportal hepatocytes
Figure 2. Comparison of the ALT activities at three age
points. At 9 weeks of age, both the rats fed with 8 ppm of FB1
and the rats with 25 ppm with FB1 showed significantly
greater ALT activity as compared with the control group. At
12 weeks of age, the rats fed with 25 ppm of FB1 showed
significantly greater ALT activity as compared with the control
group. At 20 weeks of age, both the rats fed with 8 ppm of
FB1 and the rats fed with 25 ppm of FB1 showed significantly
greater ALT activity as compared with the control group. The
error bar represents the SEM. “a” indicates significantly
greater than the control group at 9 weeks of age (N ) 4/group).
“b” indicates significantly greater than the control group at
12 weeks of age (N ) 5/group). “c” indicates significantly
greater than the control group at 20 weeks of age (N ) 10/
group).
Figure 3. (A) Comparison of the percentage of hepatic NKR-
P1bright mononuclear cells at three time points. At 9 weeks of
age, all of the rats fed FB1-glucose, 8 ppm of FB1, or 25 ppm
of FB1 exhibited greater NKR-P1bright percentage as compared
with the control group. No difference was found among
treatment groups at 12 or 20 weeks of age. The error bar
represents the SEM. (B) Comparison of the percentage of
hepatic NKR-P1dim cells at three time points. All of the rats
showed a similar percentage among treatments within the
same time point. “a” indicates significantly greater than the
control group at 9 week age (N ) 4/group). The error bar
represents the SEM.
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and mild increases of lipofuscin in the epithelium of
proximal convoluted tubules. No lesions were found in
lung, brain, or tibia.
Sphingolipid Analysis. The levels of Sa, So, and the
ratio Sa/So were not affected in any treatment group
at 9 weeks of age. The Sa concentration as well as the
ratios of Sa/So were significantly greater in the rats fed
the 25 ppm FB1 diet as compared with the control group
at 12 or 20 weeks of age. The So concentration was
unaffected among all treatment groups at 12 or 20
weeks of age (Table 3).
DISCUSSION
This study demonstrated that subjecting FB1 to a
nonenzymatic browning reaction with glucose avoided
FB1 toxicity as reflected in plasma total cholesterol
concentration, ALT activity, development of GGT- and
PGST-positive AHF, concentration of endogenous he-
patic PGE2, accumulation of Sa, or the Sa/So ratio.
These results agreed with the findings of Lu et al. (13)
in which FB1 was detoxified by reaction with fructose.
Because the FB1-fructose and FB1-glucose products are
likely to be similar, both reactions probably had similar
detoxification effects. The present study showed a lack
of toxicity of FB1-glucose over 15 weeks of treatment,
compared with a lack of toxicity over 4 weeks in an
earlier FB1-fructose detoxification study (13).
The effectiveness of the detoxification of FB1 by
reaction with glucose is probably not explained by
diminished bioavailability. FB1 when reacted with
fructose had much greater absorption than did FB1 (37).
Because FB1-fructose and FB1-glucose products are
likely to be similar, it is likely that FB1-glucose products
Figure 4. (A) Comparison of hepatic NK activity at three time
points prior to covariation with the percentage of NKR-P1bright
mononuclear cells. Activity was expressed as lytic units,
calculated from the specific lysis curve. At 9 and 12 weeks of
age, all of the rats exhibited similar NK lytic activity. At 20
weeks of age, the rats fed FB1-glucose exhibited significantly
lower NK activity as compared with the rats fed 25 ppm of
FB1. The error bar represents the SEM. (B) Comparison of
hepatic NK activity at three age stages after covariation with
the percentage of NKR-P1bright population. At three age stages,
no difference was found among treatments within each age
stage. The error bar represents the SEM. “a” indicates
significant difference as compared with the group fed 25 ppm
of FB1 (N ) 10/group).
Figure 5. Comparison of the hepatic PGE2 concentration in
four treatment groups at three time points. The concentration
of PGE2 is expressed as nanograms per gram of liver tissue.
At 9 weeks of age, there is no difference among the treatment
groups. At 12 weeks of age, no difference was found among
the treatment groups. At 20 weeks of age, the rats fed 8 or 25
ppm of FB1 exhibited significantly greater concentration of
PGE2 as compared with the control group. Rats at both 12 and
20 weeks of age had greater PGE2 concentration as compared
with the same treatment at 9 weeks of age. The error bar
represents the SEM. “a” indicates significantly greater than
the control group at 20 weeks of age (N ) 10 /group). “b”
indicates significantly greater than the 9 weeks of age group
of the same treatment.
Figure 6. Comparison of the hepatic PGF2R concentration in
four groups at three time points. The concentration of hepatic
PGF2R was expressed as nanograms per gram of liver tissure.
The is no difference among treatment groups at three time
points. The rats at both 12 and 20 weeks of age had greater
hepatic PGF2R concentration as compared with the same
treatment at 9 weeks of age. The error bar represents the
SEM. “a” indicates significant difference as compared with rats
of 9 weeks of age within the same treatment.
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were also absorbed. The addition of glucose to FB1 may
have prevented the inhibitory binding of FB1 to cer-
amide synthase, thought to be a pathway of FB1 toxicity
(14). The observation that sphingolipid ratios remained
at control values in the rats exposed to FB1-glucose in
this study further supports this assumption.
The rats fed the 25 ppm FB1 diet had noticeably
greater plasma total cholesterol concentration as com-
pared with the control group and with the rats fed FB1-
glucose at 12 weeks of age in the present study. The
observation of FB1-induced hypercholesterolemia was
reported in vervet monkeys (12), as well as in rats (11,
13). The reason that the increase of cholesterol in our
experiment was not as great as that reported in earlier
experiments might be that basal diets contained only
7% fat, which was much less than the fat content (20%)
used by Lu et al. (13). The mechanism underlying the
effect of FB1 on plasma cholesterol is unknown. The
increase in plasma total cholesterol by FB1 might result
from stimulation of cholesterol synthesis in hepatocytes
or impaired cholesterol removal by liver. We also
observed that the rats fed the 8 or 25 ppm FB1 diet had
significantly lower plasma total cholesterol level as
compared with controls or rats fed FB1-glucose at 20
weeks of age. The cholesterol levels in primary rat
hepatocytes were decreased under the effect of 500 íM
FB1 (38). The mechanism of the decrease in the levels
of cholesterol is not clear, but it could be the result of a
decreased level of sphingomyelin (SM) in cell mem-
branes that influenced cholesterol synthesis and/or
metabolism.
The plasma ALT activity was significantly increased
in rats fed 8 and 25 ppm of FB1 as compared with the
control group at 9 weeks of age. At 12 weeks of age, only
the rats fed 25 ppm of FB1 exhibited greater ALT
activity as compared with the control group. This result
is partially in agreement with the finding of Lu (37),
who found that ALT activity in rats fed 25 ppm of FB1
for 4 weeks increased significantly compared with
controls but that ALT did not increase in rats fed a 12.5
ppm of FB1 diet. This difference between our results and
the results obtained by Lu may be explained by the
greater time of FB1 exposure in the present study, which
might have caused more hepatocellular damage.
Groups fed 8 or 25 ppm of FB1 but not the group fed
FB1-glucose showed significantly greater endogenous
hepatic PGE2 as compared with the control group at 20
weeks of age. This result differed from the findings of
Lu (39), in which rats fed 50 ppm of FB1 showed greater
amounts of PGE2 and PGF2R, but no significant increase
of PGE2 or PGF2R was observed in rats fed 25 or 12.5
ppm of FB1. As with ALT, the longer period of FB1
exposure in the present study may have permitted a
lower dose of FB1 to increase PG levels. Also, as with
ALT, we have previously proposed that increased PG
production was a hallmark of promotion of rat hepato-
carcinogenesis caused by FB1 (13). However, in our
experiment, only rats fed 25 ppm of FB1 showed induc-
tion of AHF in the liver, yet rats fed 8 ppm of FB1 also
exhibited greater amounts of PGE2 but had no induction
of AHF. This suggests that the increase of PG produc-
tion may precede the occurrence of preneoplasia.
The NKR-P1bright population in rats fed FB1 or FB1-
glucose was significantly greater than in the control
group at 9 weeks of age. This might reflect a general
immune response of the host to exogenous antigen. In
vitro experiments have shown that the NK percentage
significantly increased under the effect of antigen (40).
At 12 weeks of age, all four groups had similar NKR-
P1bright percentages. At 20 weeks of age, both FB1-fed
groups had similar percentages of NKR-P1 cells com-
pared with the control group, but the percentage of
NKR-P1bright mononuclear cells in FB1-glucose-treated
rats was significantly decreased as compared with the
25 ppm FB1-treated group. Before covariation with the
percentage of NKR-P1bright population, all groups ex-
hibited similar lytic activities at 9 or 12 weeks of age,
but FB1-glucose-treated rats had significantly decreased
NK lytic activity as compared with 25 ppm FB1-treated
rats. After covariation with the percentage of NKR-
P1bright population, all four groups had similar NK lytic
activities per NK cell. Thus, FB1-glucose was not
metabolically inert. It remains to be seen whether the
suppression of NK cells by FB1-glucose is physiologically
significant, and if so, by what mechanism this occurs.
The inhibition of NK lytic activity in rats fed FB1-
glucose at 20 weeks of age probably resulted from the
decreased percentage of NKR-P1bright population.
Our results do not agree with the findings of Lu et
al. (13), who showed that hepatic NK lytic activity was
significantly inhibited when rats were fed 50 ppm of FB1
as compared with control group. Lu et al. (13) proposed
that the inhibition of NK activity might be through the
Table 2. Placental Glutathione S-Transferase (PGST)-
and ç-Glutamyl Transferase (GGT)-Positive Altered
Hepatic Foci (AHF)a
no. of
rats with
PGST AHF
% PGST
area
no. of
rats with
GGT AHF
% GGT
area
control 0 0 0 0
FB1-glucose 0 0 0 0
FB1 (8 ppm) 0 0 0 0
FB1 (25 ppm) 5 0.4 ( 0.7 5 0.6 ( 0.8
a The AHF occurred only in rats fed 25 ppm of FB1 at 20 weeks
of age. The data entries in the table are expressed as mean ( SEM.
Table 3. Comparison of Sphingosine (So), Sphinganine (Sa), and the Ratio of Sa/So at Three Time Pointsa
9 weeks of age (nmol/mL) 12 weeks of age (nmol/mL) 20 weeks of age (nmol/mL)
So Sa Sa/So So Sa Sa/So So Sa Sa/So
control 5.6 ( 1.2 0.7 ( 0.2 0.1 ( 0.1 6.5 ( 2.2 0.9 ( 0.3 0.12 ( 0.1 5.9 ( 2.5 1 ( 0.5 0.15 ( 0.1
FB1-glucose 6.5 ( 1.5 0.6 ( 0.2 0.1 ( 0.1 5.7 ( 2.5 0.8 ( 0.2 0.12 ( 0.1 5.8 ( 1.5 0.8 ( 0.5 0.12 ( 0.1
FB1 (8 ppm) 5.4 ( 2.3 0.8 ( 0.2 0.15 ( 0.1 6.3 ( 3.0 1.3 ( 0.5 0.18 ( 0.2 6.5 ( 2.9 1.2 ( 0.8 0.2 ( 0.1
FB1 (25 ppm) 5.5 ( 2.8 1.1 ( 0.3 0.2 ( 0.1 7.5 ( 3.5 3.5 ( 1.5a 0.5 ( 0.2a 5.8 ( 1.6 4.5 ( 1.5b 0.8 ( 0.3b
a The concentration of the sphingolipids is expressed as nanomoles per gram of liver tissue. At 9 weeks of age Sa, So, and the ratio
were similar among treatment groups. At 12 weeks of age the rats fed 8 or 25 ppm of FB1 diet exhibited greater Sa concentration and
increased ratio of Sa/So as compared with the control group. At 20 weeks of age, the rats fed 8 and 25 ppm of FB1 diet exhibited greater
Sa concentration and increased ratio of Sa/So as compared with the control group. The data entries in the table are expressed as mean
( SEM. “a” indicates significant difference as compared with the control group at 12 weeks of age (N ) 5/group), “b” indicates significant
difference as compared with the control group at 20 weeks of age (N ) 10/group).
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effect of increased PG production (41, 42). A dose-
response inhibition by PGE2 of NK activity had been
reported by Liu et al. (43) in cocultures of hepatic NK
cells with PGE2 in vitro. In our experiment, although
FB1 feeding increased production of PGE2, NK activity
was not affected. The reason that we did not observe
the inhibition of NK lytic activity might be that less (25
ppm) FB1 as well as less fat (7%) was fed to the rats as
compared with the experiment of Lu et al. (13; 50 ppm
of FB1 and 20% fat in the diet). A possible explanation
for the lack of effect of FB1 on NK activity in our study
may lie in interactions between carcinogenesis and NK
activity. Lee et al. (44) showed that, in male F344/rats
given 40 ppm of DEN in drinking water for 10 weeks,
as PGST-positive AHF developed, splenic NK activity
changed. After 5 weeks, DEN-treated and control rat
spleen NK activities were similar, but at 10 weeks, NK
activity was significantly greater in DEN-treated rats
compared with control rats. At 20 weeks, DEN-treated
rats had significantly lower NK activity than did control
rats. Lower NK activity was accompanied by PGST-
positive AHF. Lu et al. (13) showed a 20-fold greater
area of PGST-positive AHF as compared with our study,
which implies that with greater extent of carcinogenesis,
NK lytic activity was affected adversely.
In the present study, only half of the rats fed 25 ppm
of FB1 showed PGST- and GGT-positive AHF, in com-
parison with Lu (39) in which 11 of 12 animals fed 25
ppm of FB1 showed PGST- and GGT-positive AHF. The
area occupied by AHF was much greater than in our
study. The fat content of the diet was 20% (39), which
was much greater than the 7% fat content in our
experimental diet. High levels of dietary fat markedly
shorten the time between exposure to ultraviolet light
and its induction of skin tumors (45). Many studies have
shown that dietary fat is a tumor promoter (46, 47). In
our study, although the feeding time was longer than
in the study by Lu (39), the lesser dietary fat in the
present study might have produced fewer and smaller
GGT- and PGST-positive AHF.
Increases in free sphingosine and sphinganine in
animal tissue, serum, and urine have been used exten-
sively as an experimental biomarker for fumonisin
exposure (48). In our study, the accumulation of Sa and
the increase of the Sa/So ratio only appeared in rats fed
25 ppm of FB1 at 12 and 20 weeks of age. This did not
agree with previous observations that animals exposed
to FB1 developed altered Sa/So ratios before other signs
of toxicity were observed (14, 49). In the present study,
we observed increased ALT in both FB1-treated groups
at 9 weeks of age and in rats fed 25 ppm of FB1 at 12
weeks of age, but we did not observe the Sa/So ratio
change at 9 weeks of age. Our study agreed with the
findings of Gelderblom et al. (50), who indicated that
no significant change in Sa/So ratio was observed at the
lowest dietary level of FB1 that induced cancer promo-
tion and inhibition of cell proliferation. Further studies
are needed to determine the role of the Sa/So ratio in
fumonisin toxicity and how the effect of FB1 on this ratio
interacts with other dietary components.
Whereas both FB1-glucose and FB1 (8 ppm) diets
contained the same amount (8 ppm) of free FB1, only
rats fed FB1 (8 ppm) exhibited adverse effects, which
was reflected in increased ALT activity, total cholesterol,
and PGE2 concentrations. Rats fed FB1-glucose, which
contained 8 ppm of free FB1, showed the same lack of
toxic effects as exhibited by control rats. It seemed that
FB1-glucose prevented adverse effects of FB1 when low
concentrations of FB1 and FB1-glucose were fed to-
gether. Perhaps the FB1-glucose prevented the free FB1
from interacting with its site of action.
In conclusion, reaction of FB1 with glucose detoxified
FB1 in a rat hepatocarcinogenesis model. The mecha-
nism might be that the binding ability of FB1-glucose
to ceramide synthase was inhibited, as was reflected in
the lack of accumulation of Sa when FB1-glucose was
fed. The sphinganine/sphingosine ratio increased when
the same amount of FB1 was fed (25 ppm). Further
study is needed to determine the bioavailability of FB1-
glucose and to determine its effects in other animal
models.
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